March 20, 2018 / 6:39 AM / 4 months ago

BRIEF-Cipla Says U.S. FDA Conducted Product Specific Pre-Approval Inspection At Goa Plant In Jan

March 20 (Reuters) - Cipla Ltd:

* CLARIFIES ON NEWS ITEM REGARDING U.S. FDA OBSERVATIONS FOR CO’S GOA UNIT

* SAYS RECEIVED CERTAIN OBSERVATIONS WHICH ARE PROCEDURAL IN NATURE

* SAYS FDA CONDUCTED PRODUCT SPECIFIC PRE-APPROVAL INSPECTION AT GOA PLANT IN JANUARY 2018

* SAYS ‍"AT THIS STAGE, WE DO NOT FORESEE ANY IMPACT ON OTHER PRODUCTS BEING MANUFACTURED/FILED FROM PLANT​" Source text - bit.ly/2u83eKg Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below